Expert Ratings for Globus Medical
Portfolio Pulse from Benzinga Insights
Analysts have provided ratings for Globus Medical (NYSE:GMED) within the last quarter, with an average price target of $64.5, implying upside from the current price of $52.61. The current average has decreased by 0.77% from the previous average price target of $65.00.
May 31, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Globus Medical (NYSE:GMED) has received analyst ratings with an average price target of $64.5, implying upside from the current price of $52.61.
The average price target of $64.5 for Globus Medical (NYSE:GMED) implies an upside from the current price of $52.61. This suggests that analysts are positive about the stock's potential growth. The decrease in the average price target by 0.77% from the previous average of $65.00 indicates a slight change in analyst sentiment, but the overall outlook remains positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100